• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

New Pediatric Labeling Information Database - Detail

  • Print
  • Share
  • E-mail
Pediatric Labeling Date:  12/20/2013
Trade Name:  Isentress
Generic Name or Proper Name (*):  raltegravir
Indications Studied:  HIV-1 infection
Label Changes Summary:  *Packet for oral suspension: Approved for use in infants 4 weeks and older, weighing at least 3 kg to < 20 kg. Chewable tablet previously approved down to 2 years* Safety and dosing information have not been established in infants less than 4 weeks *Adverse reactions similar to those observed in adults* Information on dosing,clinical trial and PK parameters*Information on preparation of a suspension*New dosage form
Product Labeling:  Labeling  Opens a new window
Sponsor:  Merck Sharp & Dohme Corp.
Therapeutic Category:  Antiviral